Comparison of the Efficacy of Platelet-rich Fibrin and Connective Tissue Graft in Interdental Papilla Reconstruction

February 18, 2022 updated by: Selcen Ozcan Bulut, Hacettepe University

Comparison of the Efficacy of Platelet-rich Fibrin and Connective Tissue Graft in Interdental Papilla Reconstruction: A Retrospective Trial

Aim: To evaluate the efficacy of platelet-rich fibrin (PRF) or connective tissue graft (CTG) in papilla reconstruction (PR) with semilunar incision (SI) technique.

Materials and Methods: A total of 55 sites (27 CTG and 28 PRF) from 20 patients who underwent PR with either PRF or CTG placed with SI in the maxillary anterior region were included in the study. Baseline (BL) and follow-up (T1( first month), T3 (third month), T6 (sixth month)) clinical data including periodontal evaluations (gingival index (GI), plaque index (PI), papillary bleeding index, pocket depth (PD), keratinized tissue width (KTW), gingival recession), papilla-associated recordings (alveolar crest-interdental contact point (AC-IC), alveolar crest-papilla tip (AC-PT), papilla tip-interdental contact point (PT-IC), papilla height loss (PHL), interdental tissue stroke (ITS) and papilla presence index (PPI)) and patient satisfaction were analyzed.

Study Overview

Detailed Description

PT-IC was taken as the primary outcome measure. Normal distribution was assessed by histogram and Shapiro-Wilk test. Continuous variables were represented as mean±SD whereas the categorical variables were reported as numbers and percentages. Chi-square test was used for the comparison of the categorical variables. Since the data was normally distributed, Friedman test was used to analyze the time-dependent changes in both groups and the inter-group comparisons were made with Mann-Whitney test. Generalized Estimating Equation was used for analyzing qualitative and quantitative data, time-dependent changes, and the difference between two methods. Data analysis was performed in IBM SPSS Statistics Version 23, and p<0.05 was considered as a significance threshold.

Study Type

Observational

Enrollment (Actual)

55

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sıhhiye
      • Ankara, Sıhhiye, Turkey, 06230
        • Hacettepe University, Faculty of Dentistry, Periodontology Department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

In Hacettepe University Periodontology Department (Jun 2016-Feb 2018), 186 patients treated with PR were scanned and the data of 55 sites (27 CTG and 28 PRF) from 20 patients meeting the criteria were included.

Description

Inclusion Criteria:

  • All selected patients had consent for using their data.
  • The data of the patients who underwent PR surgery by one of the authors (S.O.B.) using SI with either PRF or CTG in the maxillary anterior teeth having contact points,
  • at least 2 mm keratinized tissue width (KTW) with probing depth (PD)≤ 3 mm adjacent to the open embrasure were included.
  • It was ensured that all baseline (BL) and follow-up data were available and all patients received a comprehensive phase I periodontal treatment prior to the PR procedure.

Exclusion Criteria:

  • the patients with systemic problems,
  • having medications known to influence the periodontium
  • Using tobacco/alcohol
  • The relevant regions did not have endodontic problems/needs, caries and history of periodontal surgery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Platelet-rich fibrin (PRF)
A total of 28 sites from 12 patients who underwent papilla reconstruction with PRF placed with semilunar incision in the maxillary anterior region were included in PRF group. ( Data of 12 patients were included in the study.)
The data of the patients who underwent papilla reconstruction surgery by one of the authors (S.O.B.) using semilunar incision with either PRF or CTG in the maxillary anterior teeth were included in the study. All selected patients had consent for using their data.The data of the patients included in the study were analyzed.(Baseline (BL) and follow-up (T1( first month) , T3 (third month), T6 (sixth month)) clinical data including periodontal evaluations (gingival index (GI), plaque index (PI), papillary bleeding index, pocket depth (PD), keratinized tissue width (KTW), gingival recession), papilla-associated recordings (alveolar crest-interdental contact point (AC-IC), alveolar crest-papilla tip (AC-PT), papilla tip-interdental contact point (PT-IC), papilla height loss (PHL), interdental tissue stroke (ITS) and papilla presence index (PPI)) and patient satisfaction were analyzed.)
Connective tissue graft (CTG)
A total of 27 sites from 8 patients who underwent papilla reconstruction with CTG placed with semilunar incision in the maxillary anterior region were included in CTG group. (Data of 8 patients were included in the study.)
The data of the patients who underwent papilla reconstruction surgery by one of the authors (S.O.B.) using semilunar incision with either PRF or CTG in the maxillary anterior teeth were included in the study. All selected patients had consent for using their data.The data of the patients included in the study were analyzed.(Baseline (BL) and follow-up (T1( first month) , T3 (third month), T6 (sixth month)) clinical data including periodontal evaluations (gingival index (GI), plaque index (PI), papillary bleeding index, pocket depth (PD), keratinized tissue width (KTW), gingival recession), papilla-associated recordings (alveolar crest-interdental contact point (AC-IC), alveolar crest-papilla tip (AC-PT), papilla tip-interdental contact point (PT-IC), papilla height loss (PHL), interdental tissue stroke (ITS) and papilla presence index (PPI)) and patient satisfaction were analyzed.)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Alveolar crest-Interdental contact point (AC-IC mm)
Time Frame: baseline
Crestal bone height was measured after administering local anesthesia for each mesiofacial or distofacial test site. UNC-15(HuFriedy, Chicago, IL, USA) periodontal probe was positioned inter-proximally in the gingival sulcus in a corono - apical direction which was parallel to the long axis of the tooth. The probe was advanced apically until it contacted the crest of the alveolar bone. The distance between the crestal bone and interdental contact point was reported as AC-IC . (measurements are in millimeters)
baseline
Alveolar crest-Interdental contact point (AC-IC mm)
Time Frame: T1:1st month
Crestal bone height was measured after administering local anesthesia for each mesiofacial or distofacial test site. UNC-15(HuFriedy, Chicago, IL, USA) periodontal probe was positioned inter-proximally in the gingival sulcus in a corono - apical direction which was parallel to the long axis of the tooth. The probe was advanced apically until it contacted the crest of the alveolar bone. The distance between the crestal bone and interdental contact point was reported as AC-IC . (measurements are in millimeters)
T1:1st month
Alveolar crest-Interdental contact point (AC-IC mm)
Time Frame: T3:3rd month
Crestal bone height was measured after administering local anesthesia for each mesiofacial or distofacial test site. UNC-15(HuFriedy, Chicago, IL, USA) periodontal probe was positioned inter-proximally in the gingival sulcus in a corono - apical direction which was parallel to the long axis of the tooth. The probe was advanced apically until it contacted the crest of the alveolar bone. The distance between the crestal bone and interdental contact point was reported as AC-IC . (measurements are in millimeters)
T3:3rd month
Alveolar crest-Interdental contact point (AC-IC mm)
Time Frame: T6: 6th month
Crestal bone height was measured after administering local anesthesia for each mesiofacial or distofacial test site. UNC-15(HuFriedy, Chicago, IL, USA) periodontal probe was positioned inter-proximally in the gingival sulcus in a corono - apical direction which was parallel to the long axis of the tooth. The probe was advanced apically until it contacted the crest of the alveolar bone. The distance between the crestal bone and interdental contact point was reported as AC-IC . (measurements are in millimeters)
T6: 6th month
Alveolar crest-Papilla tip (AC-PT mm)
Time Frame: baseline
Crestal bone height was measured after administering local anesthesia for each mesiofacial or distofacial test site. UNC-15(HuFriedy, Chicago, IL, USA) periodontal probe was positioned inter-proximally in the gingival sulcus in a corono - apical direction which was parallel to the long axis of the tooth. The probe was advanced apically until it contacted the crest of the alveolar bone. The distance between the crestal bone and the tip of the interdental papilla was reported as AC-PT. (measurements are in millimeters)
baseline
Alveolar crest-Papilla tip (AC-PT mm)
Time Frame: T1:1st month
Crestal bone height was measured after administering local anesthesia for each mesiofacial or distofacial test site. UNC-15(HuFriedy, Chicago, IL, USA) periodontal probe was positioned inter-proximally in the gingival sulcus in a corono - apical direction which was parallel to the long axis of the tooth. The probe was advanced apically until it contacted the crest of the alveolar bone. The distance between the crestal bone and the tip of the interdental papilla was reported as AC-PT. (measurements are in millimeters)
T1:1st month
Alveolar crest-Papilla tip (AC-PT mm)
Time Frame: T3:3rd month
Crestal bone height was measured after administering local anesthesia for each mesiofacial or distofacial test site. UNC-15(HuFriedy, Chicago, IL, USA) periodontal probe was positioned inter-proximally in the gingival sulcus in a corono - apical direction which was parallel to the long axis of the tooth. The probe was advanced apically until it contacted the crest of the alveolar bone. The distance between the crestal bone and the tip of the interdental papilla was reported as AC-PT. (measurements are in millimeters)
T3:3rd month
Alveolar crest-Papilla tip (AC-PT mm)
Time Frame: T6: 6th month
Crestal bone height was measured after administering local anesthesia for each mesiofacial or distofacial test site. UNC-15(HuFriedy, Chicago, IL, USA) periodontal probe was positioned inter-proximally in the gingival sulcus in a corono - apical direction which was parallel to the long axis of the tooth. The probe was advanced apically until it contacted the crest of the alveolar bone. The distance between the crestal bone and the tip of the interdental papilla was reported as AC-PT. (measurements are in millimeters)
T6: 6th month
Papilla tip-Interdental contact point (PT-IC mm)
Time Frame: baseline
the periodontal probe was positioned inter-proximally. The distance between interdental contact point and the tip of the interdental papilla was reported as PT-IC. (measurements are in millimeters)
baseline
Papilla tip-Interdental contact point (PT-IC mm)
Time Frame: T1:1st month
the periodontal probe was positioned inter-proximally. The distance between interdental contact point and the tip of the interdental papilla was reported as PT-IC. (measurements are in millimeters)
T1:1st month
Papilla tip-Interdental contact point (PT-IC mm)
Time Frame: T3:3rd month
the periodontal probe was positioned inter-proximally. The distance between interdental contact point and the tip of the interdental papilla was reported as PT-IC. (measurements are in millimeters)
T3:3rd month
Papilla tip-Interdental contact point (PT-IC mm)
Time Frame: T6: 6th month
the periodontal probe was positioned inter-proximally. The distance between interdental contact point and the tip of the interdental papilla was reported as PT-IC. (measurements are in millimeters)
T6: 6th month
Papilla Height Loss (PHL)(Nordland and Tarnow classification system)
Time Frame: baseline

Each interdental papilla was scored as 0-3 based upon Nordland and Tarnow's classification system The following scores were assigned to the papilla at baseline, T1,T3 and T6. Normal:Interdental papilla fills embrasure space to the apical extent of the interdental contact point/area.

Class-I. The tip of the interdental papilla lies between the interdental contact point and the most coronal extent of the inter proximal CEJ (the cemento-enamel junction) (space present but inter proximal CEJ is not visible) Class-II.The tip of the interdental papilla lies at or apical to the interproximal CEJ but coronal to the apical extent of the facial CEJ(interproximal CEJ visible) Class-III.The tip of the interdental papilla lies level with or apical to the facial CEJ

baseline
Papilla Height Loss (PHL)(Nordland and Tarnow classification system)
Time Frame: T1:1st month

Each interdental papilla was scored as 0-3 based upon Nordland and Tarnow's classification system The following scores were assigned to the papilla at baseline, T1,T3 and T6. Normal:Interdental papilla fills embrasure space to the apical extent of the interdental contact point/area.

Class-I. The tip of the interdental papilla lies between the interdental contact point and the most coronal extent of the inter proximal CEJ (the cemento-enamel junction) (space present but inter proximal CEJ is not visible) Class-II.The tip of the interdental papilla lies at or apical to the interproximal CEJ but coronal to the apical extent of the facial CEJ(interproximal CEJ visible) Class-III.The tip of the interdental papilla lies level with or apical to the facial CEJ

T1:1st month
Papilla Height Loss (PHL)(Nordland and Tarnow classification system)
Time Frame: T3:3rd month

Each interdental papilla was scored as 0-3 based upon Nordland and Tarnow's classification system The following scores were assigned to the papilla at baseline, T1,T3 and T6. Normal:Interdental papilla fills embrasure space to the apical extent of the interdental contact point/area.

Class-I. The tip of the interdental papilla lies between the interdental contact point and the most coronal extent of the inter proximal CEJ (the cemento-enamel junction) (space present but inter proximal CEJ is not visible) Class-II.The tip of the interdental papilla lies at or apical to the interproximal CEJ but coronal to the apical extent of the facial CEJ(interproximal CEJ visible) Class-III.The tip of the interdental papilla lies level with or apical to the facial CEJ

T3:3rd month
Papilla Height Loss (PHL)(Nordland and Tarnow classification system)
Time Frame: T6: 6th month

Each interdental papilla was scored as 0-3 based upon Nordland and Tarnow's classification system The following scores were assigned to the papilla at baseline, T1,T3 and T6. Normal:Interdental papilla fills embrasure space to the apical extent of the interdental contact point/area.

Class-I. The tip of the interdental papilla lies between the interdental contact point and the most coronal extent of the inter proximal CEJ (the cemento-enamel junction) (space present but inter proximal CEJ is not visible) Class-II.The tip of the interdental papilla lies at or apical to the interproximal CEJ but coronal to the apical extent of the facial CEJ(interproximal CEJ visible) Class-III.The tip of the interdental papilla lies level with or apical to the facial CEJ

T6: 6th month
Interdental Tissue Stroke (ITS) (Jemt's classification system)
Time Frame: baseline

The following scores were assigned to the papilla at baseline, T1,T3 and T6. Each interdental papilla was scored as 0-3 based upon Jemt's classification system

Score 0: No papilla is present

Score 1: Less than half of the height of the papilla is present

Score 2: Half or more of the height of the papilla is present

Score 3: The papilla fills up the entire proximal space

baseline
Interdental Tissue Stroke (ITS) (Jemt's classification system)
Time Frame: T1:1st month

The following scores were assigned to the papilla at baseline, T1,T3 and T6. Each interdental papilla was scored as 0-3 based upon Jemt's classification system

Score 0: No papilla is present

Score 1: Less than half of the height of the papilla is present

Score 2: Half or more of the height of the papilla is present

Score 3: The papilla fills up the entire proximal space

T1:1st month
Interdental Tissue Stroke (ITS) (Jemt's classification system)
Time Frame: T3:3rd month

The following scores were assigned to the papilla at baseline, T1,T3 and T6. Each interdental papilla was scored as 0-3 based upon Jemt's classification system

Score 0: No papilla is present

Score 1: Less than half of the height of the papilla is present

Score 2: Half or more of the height of the papilla is present

Score 3: The papilla fills up the entire proximal space

T3:3rd month
Interdental Tissue Stroke (ITS) (Jemt's classification system)
Time Frame: T6: 6th month

The following scores were assigned to the papilla at baseline, T1,T3 and T6. Each interdental papilla was scored as 0-3 based upon Jemt's classification system

Score 0: No papilla is present

Score 1: Less than half of the height of the papilla is present

Score 2: Half or more of the height of the papilla is present

Score 3: The papilla fills up the entire proximal space

T6: 6th month
Papilla presence index (PPI) (by Cardaropoli et al.)
Time Frame: baseline

The following scores were assigned to the papilla at baseline, T1,T3 and T6. PPI 1: the papilla is completely present and coronally extends to the contact point to completely fill the interproximal embrasure.

PPI 2: the papilla is no longer completely present and lies apical to the contact point. But the interproximal CEJ (iCEJ) is still not visible.

PPI 3: the papilla is moved more apical and iCEJ becomes visible. PPI 4: the papilla lies apcal to both iCEJ and buccal CEJ. Each interdental papilla was scored as 1-3 based upon PPI.

baseline
Papilla presence index (PPI) (by Cardaropoli et al.)
Time Frame: T1:1st month

The following scores were assigned to the papilla at baseline, T1,T3 and T6. PPI 1: the papilla is completely present and coronally extends to the contact point to completely fill the interproximal embrasure.

PPI 2: the papilla is no longer completely present and lies apical to the contact point. But the interproximal CEJ (iCEJ) is still not visible.

PPI 3: the papilla is moved more apical and iCEJ becomes visible. PPI 4: the papilla lies apcal to both iCEJ and buccal CEJ. Each interdental papilla was scored as 1-3 based upon PPI.

T1:1st month
Papilla presence index (PPI) (by Cardaropoli et al.)
Time Frame: T3:3rd month

The following scores were assigned to the papilla at baseline, T1,T3 and T6. PPI 1: the papilla is completely present and coronally extends to the contact point to completely fill the interproximal embrasure.

PPI 2: the papilla is no longer completely present and lies apical to the contact point. But the interproximal CEJ (iCEJ) is still not visible.

PPI 3: the papilla is moved more apical and iCEJ becomes visible. PPI 4: the papilla lies apcal to both iCEJ and buccal CEJ. Each interdental papilla was scored as 1-3 based upon PPI.

T3:3rd month
Papilla presence index (PPI) (by Cardaropoli et al.)
Time Frame: T6: 6th month

The following scores were assigned to the papilla at baseline, T1,T3 and T6. PPI 1: the papilla is completely present and coronally extends to the contact point to completely fill the interproximal embrasure.

PPI 2: the papilla is no longer completely present and lies apical to the contact point. But the interproximal CEJ (iCEJ) is still not visible.

PPI 3: the papilla is moved more apical and iCEJ becomes visible. PPI 4: the papilla lies apcal to both iCEJ and buccal CEJ. Each interdental papilla was scored as 1-3 based upon PPI.

T6: 6th month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gingival index (GI) ( by Löe & Silness 1963)
Time Frame: baseline

The Gingival Index (GI) scores each site on a 0 to 3 scale, with 0 being normal and 3 being severe inflammation characterized by edema, redness, swelling, and spontaneous bleeding.

The GI uses the following scoring system:

0 = normal gingiva

  1. = mild inflammation: slight change in color, slight edema, no bleeding on probing
  2. = moderate inflammation: redness, edema, and glazing, or bleeding on probing
  3. = severe inflammation: marked redness and edema, tendency toward spontaneous bleeding, ulceration The GI of the individual can be obtained by adding the values of each tooth and dividing by the number of teeth examined.
baseline
Gingival index (GI) ( by Löe & Silness 1963)
Time Frame: T1:1st month

The Gingival Index (GI) scores each site on a 0 to 3 scale, with 0 being normal and 3 being severe inflammation characterized by edema, redness, swelling, and spontaneous bleeding.

The GI uses the following scoring system:

0 = normal gingiva

  1. = mild inflammation: slight change in color, slight edema, no bleeding on probing
  2. = moderate inflammation: redness, edema, and glazing, or bleeding on probing
  3. = severe inflammation: marked redness and edema, tendency toward spontaneous bleeding, ulceration The GI of the individual can be obtained by adding the values of each tooth and dividing by the number of teeth examined.
T1:1st month
Gingival index (GI) ( by Löe & Silness 1963)
Time Frame: T3:3rd month

The Gingival Index (GI) scores each site on a 0 to 3 scale, with 0 being normal and 3 being severe inflammation characterized by edema, redness, swelling, and spontaneous bleeding.

The GI uses the following scoring system:

0 = normal gingiva

  1. = mild inflammation: slight change in color, slight edema, no bleeding on probing
  2. = moderate inflammation: redness, edema, and glazing, or bleeding on probing
  3. = severe inflammation: marked redness and edema, tendency toward spontaneous bleeding, ulceration The GI of the individual can be obtained by adding the values of each tooth and dividing by the number of teeth examined.
T3:3rd month
Gingival index (GI) ( by Löe & Silness 1963)
Time Frame: T6: 6th month

The Gingival Index (GI) scores each site on a 0 to 3 scale, with 0 being normal and 3 being severe inflammation characterized by edema, redness, swelling, and spontaneous bleeding.

The GI uses the following scoring system:

0 = normal gingiva

  1. = mild inflammation: slight change in color, slight edema, no bleeding on probing
  2. = moderate inflammation: redness, edema, and glazing, or bleeding on probing
  3. = severe inflammation: marked redness and edema, tendency toward spontaneous bleeding, ulceration The GI of the individual can be obtained by adding the values of each tooth and dividing by the number of teeth examined.
T6: 6th month
Gingival recession (GR-mm)
Time Frame: baseline

The distance between buccal CEJ and the most coronal extent marginal gingiva was reported as GR.

(measurements are in millimeters)

baseline
Gingival recession (GR-mm)
Time Frame: T1:1st month

The distance between buccal CEJ and the most coronal extent marginal gingiva was reported as GR.

(measurements are in millimeters)

T1:1st month
Gingival recession (GR-mm)
Time Frame: T3:3rd month

The distance between buccal CEJ and the most coronal extent marginal gingiva was reported as GR.

(measurements are in millimeters)

T3:3rd month
Gingival recession (GR-mm)
Time Frame: T6: 6th month

The distance between buccal CEJ and the most coronal extent marginal gingiva was reported as GR.

(measurements are in millimeters)

T6: 6th month
Keratinized tissue width (KTW-mm)
Time Frame: baseline
It extends from the free gingival margin to the mucogingival junction and consists of the free gingiva as well as the attached gingiva. The distance between the most coronal extent free gingiva in buccal and the most coronal extent mucogingival junction was reported as KTW. (measurements are in millimeters)
baseline
Keratinized tissue width (KTW-mm)
Time Frame: T1:1st month
It extends from the free gingival margin to the mucogingival junction and consists of the free gingiva as well as the attached gingiva. The distance between the most coronal extent free gingiva in buccal and the most coronal extent mucogingival junction was reported as KTW. (measurements are in millimeters)
T1:1st month
Keratinized tissue width (KTW-mm)
Time Frame: T3:3rd month
It extends from the free gingival margin to the mucogingival junction and consists of the free gingiva as well as the attached gingiva. The distance between the most coronal extent free gingiva in buccal and the most coronal extent mucogingival junction was reported as KTW. (measurements are in millimeters)
T3:3rd month
Keratinized tissue width (KTW-mm)
Time Frame: T6: 6th month
It extends from the free gingival margin to the mucogingival junction and consists of the free gingiva as well as the attached gingiva. The distance between the most coronal extent free gingiva in buccal and the most coronal extent mucogingival junction was reported as KTW. (measurements are in millimeters)
T6: 6th month
Pocket depth (PD-mm)
Time Frame: baseline
Periodontal probe was positioned in the gingival sulcus . The distance between the top of the free gingiva and the bottom of the sulcus was reported as PD. (measurements are in millimeters)
baseline
Pocket depth (PD-mm)
Time Frame: T1:1st month
Periodontal probe was positioned in the gingival sulcus . The distance between the top of the free gingiva and the bottom of the sulcus was reported as PD. (measurements are in millimeters)
T1:1st month
Pocket depth (PD-mm)
Time Frame: T3:3rd month
Periodontal probe was positioned in the gingival sulcus . The distance between the top of the free gingiva and the bottom of the sulcus was reported as PD. (measurements are in millimeters)
T3:3rd month
Pocket depth (PD-mm)
Time Frame: T6: 6th month
Periodontal probe was positioned in the gingival sulcus . The distance between the top of the free gingiva and the bottom of the sulcus was reported as PD. (measurements are in millimeters)
T6: 6th month
Plaque index (PI) (by Silness & Löe 1964 )
Time Frame: baseline

0- No plaque

  1. -A film of plaque adhering to the free gingival margin and adjacent area of the tooth. The plaque may be seen in situ only after application of disclosing solution or by using the probe on the tooth surface.
  2. -Moderate accumulation of soft deposit s within the gingival pocket, or the tooth and gingival margin which can be seen with the naked eye.
  3. -Abundance of soft matter within the gingival pocket and/or on the tooth and gingival margin.

The PI of the individual can be obtained by adding the values of each tooth and dividing by the number of teeth examined.

baseline
Plaque index (PI) (by Silness & Löe 1964 )
Time Frame: T1:1st month

0- No plaque

  1. -A film of plaque adhering to the free gingival margin and adjacent area of the tooth. The plaque may be seen in situ only after application of disclosing solution or by using the probe on the tooth surface.
  2. -Moderate accumulation of soft deposit s within the gingival pocket, or the tooth and gingival margin which can be seen with the naked eye.
  3. -Abundance of soft matter within the gingival pocket and/or on the tooth and gingival margin.

The PI of the individual can be obtained by adding the values of each tooth and dividing by the number of teeth examined.

T1:1st month
Plaque index (PI) (by Silness & Löe 1964 )
Time Frame: T3:3rd month

0- No plaque

  1. -A film of plaque adhering to the free gingival margin and adjacent area of the tooth. The plaque may be seen in situ only after application of disclosing solution or by using the probe on the tooth surface.
  2. -Moderate accumulation of soft deposit s within the gingival pocket, or the tooth and gingival margin which can be seen with the naked eye.
  3. -Abundance of soft matter within the gingival pocket and/or on the tooth and gingival margin.

The PI of the individual can be obtained by adding the values of each tooth and dividing by the number of teeth examined.

T3:3rd month
Plaque index (PI) (by Silness & Löe 1964 )
Time Frame: T6: 6th month

0- No plaque

  1. -A film of plaque adhering to the free gingival margin and adjacent area of the tooth. The plaque may be seen in situ only after application of disclosing solution or by using the probe on the tooth surface.
  2. -Moderate accumulation of soft deposit s within the gingival pocket, or the tooth and gingival margin which can be seen with the naked eye.
  3. -Abundance of soft matter within the gingival pocket and/or on the tooth and gingival margin.

The PI of the individual can be obtained by adding the values of each tooth and dividing by the number of teeth examined.

T6: 6th month
Papillary Bleeding Index(PBI) (by Saxer & Muhlemann 1975)
Time Frame: baseline

The PBI has proven to be particularly useful for assessing inflammation in the interdental papillae by recording bleeding on probing in the interdental areas during the course of treatment.

Grade 0- no bleeding, normal papilla Grade 1- 20-30 seconds after probing the mesial and distal sulcus with a periodontal probe, a single bleeding point is observed.

Grade 2- A fine line of blood or several bleeding points become visible at the gingival margin.

Grade 3- Triangle The interdental triangle becomes more or less filled with blood Grade 4- Immediately after probing, blood flows into the interdental area to cover portions of the tooth and/or gingiva The PBI is calculated by dividing the bleeding number by the total number of papilla examined.

baseline
Papillary Bleeding Index(PBI) (by Saxer & Muhlemann 1975)
Time Frame: T1:1st month

The PBI has proven to be particularly useful for assessing inflammation in the interdental papillae by recording bleeding on probing in the interdental areas during the course of treatment.

Grade 0- no bleeding, normal papilla Grade 1- 20-30 seconds after probing the mesial and distal sulcus with a periodontal probe, a single bleeding point is observed.

Grade 2- A fine line of blood or several bleeding points become visible at the gingival margin.

Grade 3- Triangle The interdental triangle becomes more or less filled with blood Grade 4- Immediately after probing, blood flows into the interdental area to cover portions of the tooth and/or gingiva The PBI is calculated by dividing the bleeding number by the total number of papilla examined.

T1:1st month
Papillary Bleeding Index(PBI) (by Saxer & Muhlemann 1975)
Time Frame: T3:3rd month

The PBI has proven to be particularly useful for assessing inflammation in the interdental papillae by recording bleeding on probing in the interdental areas during the course of treatment.

Grade 0- no bleeding, normal papilla Grade 1- 20-30 seconds after probing the mesial and distal sulcus with a periodontal probe, a single bleeding point is observed.

Grade 2- A fine line of blood or several bleeding points become visible at the gingival margin.

Grade 3- Triangle The interdental triangle becomes more or less filled with blood Grade 4- Immediately after probing, blood flows into the interdental area to cover portions of the tooth and/or gingiva The PBI is calculated by dividing the bleeding number by the total number of papilla examined.

T3:3rd month
Papillary Bleeding Index(PBI) (by Saxer & Muhlemann 1975)
Time Frame: T6: 6th month

The PBI has proven to be particularly useful for assessing inflammation in the interdental papillae by recording bleeding on probing in the interdental areas during the course of treatment.

Grade 0- no bleeding, normal papilla Grade 1- 20-30 seconds after probing the mesial and distal sulcus with a periodontal probe, a single bleeding point is observed.

Grade 2- A fine line of blood or several bleeding points become visible at the gingival margin.

Grade 3- Triangle The interdental triangle becomes more or less filled with blood Grade 4- Immediately after probing, blood flows into the interdental area to cover portions of the tooth and/or gingiva The PBI is calculated by dividing the bleeding number by the total number of papilla examined.

T6: 6th month
Patient-based variables
Time Frame: T1:1st month
Evaluation was made using the Visual Analog Scale( VAS- 0-10). The experienced pain values, the aesthetic expectations , The gained aesthetics / difficulty variables. these three criteria were evaluated together ( patient satisfaction )
T1:1st month
Patient-based variables
Time Frame: T3:3rd month
Evaluation was made using the Visual Analog Scale( VAS- 0-10). The experienced pain values, the aesthetic expectations , The gained aesthetics / difficulty variables. these three criteria were evaluated together ( patient satisfaction )
T3:3rd month
Patient-based variables
Time Frame: T6: 6th month
Evaluation was made using the Visual Analog Scale( VAS- 0-10). The experienced pain values, the aesthetic expectations , The gained aesthetics / difficulty variables. these three criteria were evaluated together ( patient satisfaction )
T6: 6th month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 5, 2018

Primary Completion (ACTUAL)

November 1, 2018

Study Completion (ACTUAL)

December 18, 2018

Study Registration Dates

First Submitted

December 1, 2021

First Submitted That Met QC Criteria

January 12, 2022

First Posted (ACTUAL)

January 26, 2022

Study Record Updates

Last Update Posted (ACTUAL)

March 7, 2022

Last Update Submitted That Met QC Criteria

February 18, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • GO 18/780

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on To Evaluate the Efficacy of Platelet-rich Fibrin in Papilla Reconstruction

Clinical Trials on retrospective data analysis

Subscribe